Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation
Close
Home
BioJet
About Us
News
Publications
Toggle the search bar
Search the Site
Close the mobile navigation
Reimagining the delivery of biologics
Needle-free, oral delivery of large molecules designed to replace injection for better management of chronic diseases.
about biojet
News
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
Sep 10, 2026
Biora Therapeutics featured in Featured in Frost & Sullivan’s 2026 Frost Radar
May 18, 2026
Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
Apr 8, 2026
See More
Publications
Single ascending dose results from a Phase 1 clinical trial of BT-600, a combination product of the NaviCap™ targeted oral delivery platform and tofacitinib
October 28, 2024
#NaviCap Targeted Therapeutic Delivery
Results of human device function studies for the NaviCap™ Targeted Oral Delivery Platform in healthy volunteers and patients with UC
May 18, 2024
#NaviCap Targeted Therapeutic Delivery
Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model: an update
October 4, 2023
#BioJet Oral Therapeutic Delivery
See More